Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Hemodynamic Tolerance of Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial

NCT04714710 is registered in ClinicalTrials.gov with Pr. Nicolas GIRERD as lead sponsor.

NCT NCT04714710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04714710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Hemodynamic Tolerance of Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial
Lead sponsor
Pr. Nicolas GIRERD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 26, 2021
Completion date
December 6, 2033
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain-dead organ donors